Reversine ameliorates hallmarks of cellular senescence in human skeletal myoblasts via reactivation of autophagy

Aging Cell. 2023 Mar;22(3):e13764. doi: 10.1111/acel.13764. Epub 2023 Jan 10.

Abstract

Cellular senescence leads to the depletion of myogenic progenitors and decreased regenerative capacity. We show that the small molecule 2,6-disubstituted purine, reversine, can improve some well-known hallmarks of cellular aging in senescent myoblast cells. Reversine reactivated autophagy and insulin signaling pathway via upregulation of Adenosine Monophosphate-activated protein kinase (AMPK) and Akt2, restoring insulin sensitivity and glucose uptake in senescent cells. Reversine also restored the loss of connectivity of glycolysis to the TCA cycle, thus restoring dysfunctional mitochondria and the impaired myogenic differentiation potential of senescent myoblasts. Altogether, our data suggest that cellular senescence can be reversed by treatment with a single small molecule without employing genetic reprogramming technologies.

Keywords: aging; cellular senescence; metabolism; methionine pathway; skeletal muscle.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AMP-Activated Protein Kinase Kinases / metabolism
  • Autophagy* / drug effects
  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • Citric Acid Cycle / drug effects
  • Glycolysis / drug effects
  • Humans
  • Insulin / metabolism
  • Insulin Resistance
  • Morpholines* / pharmacology
  • Muscle Development* / drug effects
  • Myoblasts, Skeletal* / drug effects
  • Myoblasts, Skeletal* / physiology
  • Protein Kinase Inhibitors* / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • Purines* / pharmacology
  • Signal Transduction / drug effects

Substances

  • 2-(4-morpholinoanilino)-6-cyclohexylaminopurine
  • Morpholines
  • Purines
  • Protein Kinase Inhibitors
  • Insulin
  • AMP-Activated Protein Kinase Kinases
  • AKT2 protein, human
  • Proto-Oncogene Proteins c-akt